05:36 PM EDT, 10/10/2025 (MT Newswires) -- Jack A. Khattar, Director, President, CEO, on October 09, 2025, sold 59,900 shares in Supernus Pharmaceuticals ( SUPN ) for $3,029,336. Following the Form 4 filing with the SEC, Khattar has control over a total of 2,212,178 common shares of the company, with 1,206,578 shares held directly and 1,005,600 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1356576/000162828025044830/xslF345X05/wk-form4_1760132000.xml